Drugs and the fetomaternal unit

Area of Science:

• Pharmacology
• Neonatal Health
• Maternal-Fetal Medicine

Background:

• Drug administration during pregnancy is frequent for various maternal conditions.
• Significant knowledge gaps exist regarding maternal pharmacokinetics and infant drug exposure.
• The short- and long-term effects of medications on newborns are largely unknown.

Purpose of the Study:

• To review the current understanding of drug transfer from mother to fetus.
• To identify factors influencing drug disposition during pregnancy.
• To consolidate available knowledge on medication effects in neonates.

Main Methods:

• Literature review of existing studies on maternal-fetal drug transfer.
• Analysis of pharmacokinetic principles governing drug movement across the placenta.
• Synthesis of data on known drug effects in the neonatal population.

Main Results:

• Drug transfer is influenced by factors such as maternal and fetal physiology, and drug properties.
• Limited data exists on the comprehensive pharmacokinetic profiles of many drugs in pregnant women.
• The impact of in utero drug exposure on infant development requires further extensive research.

Conclusions:

• Understanding maternal pharmacokinetics is crucial for assessing neonatal drug exposure risks.
• Further research is essential to elucidate the long-term consequences of medications used during pregnancy.
• Comprehensive knowledge on drug transfer is vital for optimizing maternal and infant safety.